Heart Tissue Risk Visualization Using Non-Invasive Phase Space Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for visualizing coronary artery blockages and myocardium at risk are invasive, costly, and carry risks such as stroke and radiation exposure, while also being time-consuming and requiring expertise for interpretation.

Innovation Solution

The development of a non-invasive system that uses phase space tomography analysis to present data in a graphical user interface, allowing for three-dimensional and two-dimensional visualizations of myocardial tissue, coronary arteries, and predicted CAD status, facilitating intuitive and unified visualization for diagnosis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If invasive procedures such as coronary angiography are used to measure occlusion size and blood flow, then measurement precision is improved, but object-affected harmful factors increase due to risks of stroke, heart attack, radiation exposure, and injury

Engineering Contradiction:
Improveocclusion size and blood flow measurementVSAvoidrisks of stroke, heart attack, radiation exposure, and injury
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical/invasive catheter-based measurement system with a non-invasive electrical measurement system that uses body surface potential maps to assess coronary artery disease, thereby eliminating the harmful effects of invasive procedures while maintaining diagnostic capability

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an intermediary computational model that translates non-invasive electrical measurements into meaningful diagnostic information about coronary artery blockages, allowing accurate assessment without direct physical intrusion into the vascular system

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If invasive catheterization procedures are performed to evaluate coronary arteries, then measurement precision is improved, but loss of time increases due to the lengthy and complex nature of the procedure

Engineering Contradiction:
Improvecoronary artery evaluationVSAvoidprocedure duration
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent substitutes the time-consuming mechanical catheterization process with a rapid non-invasive electrical measurement approach that can be performed quickly without the need for complex procedural setup and interpretation

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Object-affected harmful factors

If contemporary techniques using surface cardiac gradient analysis are used, then object-generated harmful factors are reduced by avoiding invasive procedures, but difficulty of detecting and measuring increases due to noise contamination and challenge in discriminating pertinent information

Engineering Contradiction:
Improveinvasive procedure risksVSAvoidsignal discrimination and noise filtering
Core Design Contradiction:
Object-affected harmful factorsVSDifficulty of detecting and measuring

Solution Approach 1:

The patent introduces an intermediary computational processing layer that filters and interprets the noisy electrical signals from the body surface, extracting meaningful diagnostic information about coronary artery disease while eliminating the need for invasive measurement

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a computational model that replicates the diagnostic information obtainable from invasive procedures by analyzing patterns in non-invasive electrical measurements, effectively copying the diagnostic value without the harmful effects

Inventive Principle:
Principle #26Copying

Data Source

PatentEP3516562B1Method and system for visualization of heart tissue at risk
Publication Date: 2025.02.12 ANALYTICS FOR LIFE
  • EP3516562B1 patent drawingFigure 1
  • EP3516562B1 patent drawingFigure 2
  • EP3516562B1 patent drawingFigure 3

AI summary

Exemplified methods and systems facilitate presentation of data derived from measurements of the heart in a non-invasive procedure (e.g., via phase space tomography analysis). In particular, the exemplified methods and systems facilitate presentation of such measurements in a graphical user interface, or "GUI" (e.g., associated with a healthcare provider web portal to be used by physicians, researchers, or patients, and etc.) and/or in a report for diagnosis of heart pathologies and disease. The presentation facilitates a unified and intuitive visualization that includes three-dimensional visualizations and two-dimensional visualizations that are concurrently presented within a single interactive interface and/or report.